Strontium: Postmenopausal osteoporosis: Too many unknowns

Prescrire International

Volumn 14, Issue 80, 2005, Pages 207-211

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CREATINE KINASE; ESTROGEN; ETIDRONIC ACID; FLUORIDE; PARATHYROID HORMONE[1-34]; PLACEBO; RALOXIFENE; RISEDRONIC ACID; STRONTIUM RANELATE; VITAMIN D; BONE DENSITY CONSERVATION AGENT; STRONTIUM;

ABDOMINAL PAIN; AGING; AMNESIA; ARTICLE; BONE DENSITY; BONE FRAGILITY; BONE MINERALIZATION; BONE NECROSIS; BRAIN DISEASE; BREAST CANCER; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; CONSTIPATION; DIARRHEA; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; DYSPEPSIA; ESOPHAGITIS; EYE DISEASE; FEMALE; FLUOROSIS; GASTROINTESTINAL SYMPTOM; HEADACHE; HIP FRACTURE; HUMAN; HYPOCALCEMIA; ISCHEMIC HEART DISEASE; JAW DISEASE; KIDNEY FAILURE; LUNG EMBOLISM; MUSCLE DISEASE; NEUROLOGIC DISEASE; NONHUMAN; OSTEOMALACIA; POSTMENOPAUSE OSTEOPOROSIS; PRIMARY PREVENTION; RISK REDUCTION; SECONDARY PREVENTION; SEIZURE; STROKE; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; VERTEBRA FRACTURE; AGED; COMPARATIVE STUDY; DRUG EFFECT; FRACTURE; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ALENDRONATE; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CALCIUM; CLINICAL TRIALS; FEMALE; FRACTURES, BONE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; STRONTIUM; TERIPARATIDE; TREATMENT OUTCOME; VITAMIN D;

EID: 28644446711     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. "Osteoporosis". In "Martindale The complete drug reference" 34th ed., The Pharmaceutical Press, London 2005: 763-764.
2. Bruyere O et al. "Fracture prevention in postmenopausal women" Clin Evid 2004; 12: 1594-1611.
3. Cauley JA et al. "Effects of estrogen plus progestin on risk of fracture and bone mineral density. The Women's Health Initiative randomized trial" JAMA 2003; 290 (13): 1729-1738.
4. Prescrire Editorial Staff "Postmenopausal hormone therapy: cardiovascular risks" Prescrire Int 2003; 12 (64): 65-69.
5. Prescrire Rédaction "Traitement hormonal substitutif de la ménopause et cancer: attention au sein !" Rev Prescrire 2003; 23 (235): 28.
6. Prescrire Editorial Staff "Risk-benefit balance of postmenopausal hormone replacement therapy" Prescrire Int 2004, 13 (71): 106-109.
7. Prescrire Editorial Staff "Raloxifene" Prescrire Int 1999; 8 (44): 165-167.
8. Prescrire Editorial Staff "Raloxifene and prevention of vertebral fracture" Prescrire Int 2000; 9 (50): 190-191.
9. Prescrire Editorial Staff "Alendronic add" Prescrire Int 1998; 7 (34): 38-40.
10. Prescrire Editorial Staff "Alendronic add" Prescrire Int 2000; 9 (47): 70-72.
11. Prescrire Rédaction "acide alendronique - Fosamax°. Le "nouveau libellé d'AMM" n'est qu'un tour de passe-passe" Rev Prescrire 2001; 21 (220): 573.
12. Prescrire Editorial Staff "Risedronic acid" Prescrire Int 2002; 12 (59): 94.
13. Prescrire Editorial Staff "Alendronic acid tab 70 mg weekly" Prescrire Int 2003; 12 (66): 140.
14. Prescrire Rédaction "acide risédronique - Actonel°. Nouveau dosage pour une prise par semaine, pas mieux que l'acide alendronique" Rev Prescrire 2003; 23 (244): 732-733.
15. National Health Services - London New Drugs Group "Strontium ranelate" December 2004: 18 pages.
16. Black DM et al. "Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures" Lancet 1996; 348: 1535-1541.
17. Odvina CV et al. "Severely suppressed bone turnover: a potential complication of alendronate therapy" J Clin Endocrinol Metab 2005; 90 (3): 1294-1301.
18. Prescrire Editorial Staff "Teriparatide" Prescrire Int 2005; 14 (75): 5-9.
19. European Medicines Agency - Committee for Human Medicinal Products "European Public Assessment Report - Protelos. Scientific discussion" Rev. 1, 21 September 2004: 25 pages.
20. Fuleihan GEH "Strontium ranelate - A novel therapy for osteoporosis or a permutation of the same?" N Engl J Med 2004, 350 (5): 504-506.
21. Reginster JY et al. "Prevention of early post menopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo controlled PREVOS trial" Osteoporos Int 2002; 13 (12): 925-931.
22. Reginster JY and Meunier PJ "Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies" Osteoporos Int 2003; 14 (suppl. 3): 56-65.
23. Meunier PJ et al. "Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis. A 2-year randomized placebo controlled trial" J Clin Endocrinol Metab 2002; 87 (5): 2060-2066.
24. Meunier PJ et al. "The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis" N Engl J Med 2004; 350 (5): 459-468 + (letters) 350 (19): 2001-2003.
25. Reginster JY et al. "A new treatment for the reduction of vertebral and non-vertebral fractures in post-menopausal women with osteoporosis" American Congress of Rheumatology 2004; abstr. n° 50 (1 page).
26. "Alendronic acid". In: "Martindale The complete drug reference" 34th ed, The Pharmaceutical Press London 2005: 765-766.
27. Prescrire Rédaction "Ostéonécroses de la mâchoire sous diphosphonate" Rev Prescrire 2004; 24 (256): 833.
28. Ammann P et al. "Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats" J Bone Miner Res 2004; 19 (12): 2012-2020.
29. Cohen-Solal M "Strontium overload and toxicity: impact on renal osteodystrophy" Nephrol Dial Transplant 2002; 17 (suppl. 2): 30-34.
30. d'Haese PC et al. "Increased bone strontium levels in hemodialysis patients with osteomalacia" Kidney Int 2000; 57: 1107-1114.
31. Prescrire Rédaction "Ostéofluor°" Rev Prescrire 1985; 5 (45): 3-4.
32. Prescrire Editorial Staff "Very late withdrawal of fluorides" Prescrire Int 2002; 11 (64): 92.
33. European Medicines Agency - CHMP "EPAR - Protelos - Summary of Product Characteristics" 21 September 2004: 11 pages.
34. Prescrire Rédaction "étidronate - Didronel°" Rev Prescrire 1994; 14 (141): 328.
35. "Fosamax°" Physicians' Desk Reference, Thomson-PDR, Montvale 2005: 2049-2057.